Creon and Malignant neoplasm progression - a phase IV clinical study of FDA data
Summary:
Malignant neoplasm progression is reported as a side effect among people who take Creon (pancrelipase (amylase;lipase;protease)), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Metformin, and have Neuroendocrine tumor.
The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Creon. It is created by eHealthMe based on reports of 29,220 people who have side effects when taking Creon from the FDA, and is updated regularly.
What is Creon?
Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.
What is Malignant neoplasm progression?
Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,508 drugs and 1,637 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
29,220 people reported to have side effects when taking Creon.
Among them, 153 people (0.52%) have Malignant neoplasm progression.
Among these 153 people:
How long have people been on Creon when they have Malignant neoplasm progression? *
What is the gender of people who have Malignant neoplasm progression when taking Creon? *
What is the age of people who have Malignant neoplasm progression when taking Creon? *
What are other drugs people take besides Creon? *
What are other side effects people have besides Malignant neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Creon and have Malignant neoplasm progression?
- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Creon:
- Creon (29,489 reports)
Malignant neoplasm progression treatments and more:
- Malignant neoplasm progression (107,528 reports)
How severe was Malignant neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of pancrelipase (amylase;lipase;protease):
- Malignant neoplasm progression and drugs with ingredients of pancrelipase (amylase;lipase;protease) (238 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Creon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,508 drugs)
Browse all the conditions that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,637 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) (the active ingredients of Creon) and Creon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Imodium cause Malaise? - a second ago
- Ritalin and Death for Men aged 50-59 - 5 seconds ago
- Ritalin and Sudden Death for Men aged 50-59 - 5 seconds ago
- Ritalin and Death Sudden for Men aged 50-59 - 6 seconds ago
- Drug interactions of Nystatin and Aspirin - 7 seconds ago
- Could Carbamazepine cause Impaired Driving Ability? - 11 seconds ago
- Could Adenosine cause Wheezing? - 12 seconds ago
- Could Coumadin cause Hepatic Enzyme Abnormal? - 13 seconds ago
- Drug interactions of Magnesium Citrate and Zoloft - 17 seconds ago
- Could Coumadin cause Bacterial Infection? - 23 seconds ago